These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 37497684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y, Wang Q, Zhang Z, Zhao C, Zhou H, Xu J, Gu Q.
    Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
    [Abstract] [Full Text] [Related]

  • 3. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z, Li W, Ai J, Xie J, Zhang X.
    J Transl Med; 2022 Jun 08; 20(1):264. PubMed ID: 35676661
    [Abstract] [Full Text] [Related]

  • 4. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway.
    Wang J, Shang Y, Wang Y, Li Y, Wang L, Huang S, Lyu X.
    Histol Histopathol; 2024 May 08; 39(5):647-657. PubMed ID: 37971211
    [Abstract] [Full Text] [Related]

  • 5. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
    Xiong W, Li D, Ao F, Tu Z, Xiong J.
    Cell Biochem Funct; 2024 Mar 08; 42(2):e3939. PubMed ID: 38454810
    [Abstract] [Full Text] [Related]

  • 6. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
    Huang P, Li M, Tang Q, Jiang K, Luo Y.
    Apoptosis; 2022 Oct 08; 27(9-10):751-761. PubMed ID: 35759163
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
    Li DP, Chai W, Liu YH, Xu TT, Huang H.
    Eur Rev Med Pharmacol Sci; 2019 May 08; 23(9):3806-3812. PubMed ID: 31115007
    [Abstract] [Full Text] [Related]

  • 8. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis.
    Xu M, Fan Y, Zou G, Yang Q, Xu F.
    Cell Mol Biol (Noisy-le-grand); 2024 Mar 31; 70(3):130-135. PubMed ID: 38650146
    [Abstract] [Full Text] [Related]

  • 9. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W.
    FASEB J; 2019 Nov 31; 33(11):11959-11972. PubMed ID: 31408612
    [Abstract] [Full Text] [Related]

  • 10. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN, Zhu H, Li LP, Jin AY, Wang HQ.
    Eur Rev Med Pharmacol Sci; 2019 Sep 31; 23(18):7935-7942. PubMed ID: 31599418
    [Abstract] [Full Text] [Related]

  • 11. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X, Xiong G, Chen W, Fu H, Li M, Cui X.
    Biochem Cell Biol; 2020 Dec 31; 98(6):653-660. PubMed ID: 32459973
    [Abstract] [Full Text] [Related]

  • 12. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
    Zhang W, Zhang Q, Cui Q, Xu Y.
    Hum Exp Toxicol; 2023 Dec 31; 42():9603271221150248. PubMed ID: 36607163
    [Abstract] [Full Text] [Related]

  • 13. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT, Wang HC, Chuang HC, Hsu YC, Yang MY, Chien CY.
    J Mol Med (Berl); 2018 Dec 31; 96(12):1407-1418. PubMed ID: 30374682
    [Abstract] [Full Text] [Related]

  • 14. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z, Ruinian Z, Liji J, Chun Z, Qiaolan Z, Jun J, Yuming C, Junrong H.
    Technol Cancer Res Treat; 2020 Dec 31; 19():1533033819892251. PubMed ID: 31984860
    [Abstract] [Full Text] [Related]

  • 15. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K, Zhao J, Xu H, Yan X, Liu W, Jiang X, Ren C.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun 28; 47(6):685-697. PubMed ID: 35837768
    [Abstract] [Full Text] [Related]

  • 16. Tumor suppressor functions of miRNA-375 in nasopharyngeal carcinoma through inhibition of ubiquitin-specific protease 1 expression.
    Xu J, Li B, Song W, Cao L, Zhu C, Lin S.
    Int J Biochem Cell Biol; 2021 Dec 28; 141():106092. PubMed ID: 34626803
    [Abstract] [Full Text] [Related]

  • 17. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X, Jin Q, Wang X, Chen W, Cai Z.
    Cancer Biomark; 2019 Dec 28; 26(2):171-182. PubMed ID: 31403940
    [Abstract] [Full Text] [Related]

  • 18. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B, Gu Q, Li J.
    Oncol Rep; 2017 Jul 28; 38(1):317-324. PubMed ID: 28586035
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q, Hou S, Zhu X, Liu S.
    World J Surg Oncol; 2020 Feb 03; 18(1):29. PubMed ID: 32013999
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
    Hu W, Wang Y, Zhang Q, Luo Q, Huang N, Chen R, Tang X, Li X, Luo H.
    Cell Signal; 2023 Oct 03; 110():110833. PubMed ID: 37543098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.